The combination inhaler ipratropium bromide and albuterol (Combivent) is considered the best option for managing which condition?

Prepare for the PANCE Board Exam with our comprehensive quiz. Study with detailed questions and explanations. Sharpen your skills and boost your confidence for exam day!

Multiple Choice

The combination inhaler ipratropium bromide and albuterol (Combivent) is considered the best option for managing which condition?

Explanation:
In COPD, combining a short-acting muscarinic antagonist with a short-acting beta-agonist provides greater bronchodilation by blocking cholinergic bronchoconstriction and stimulating beta-2–mediated smooth muscle relaxation. This dual approach addresses the two main pathways that tighten airways in COPD, offering better symptom relief than either agent alone. In asthma, beta-agonists are central and anticholinergics add limited additional benefit; steroids like Solumedrol are reserved for acute exacerbations, not maintenance therapy. So the combo inhaler is the best option for COPD management.

In COPD, combining a short-acting muscarinic antagonist with a short-acting beta-agonist provides greater bronchodilation by blocking cholinergic bronchoconstriction and stimulating beta-2–mediated smooth muscle relaxation. This dual approach addresses the two main pathways that tighten airways in COPD, offering better symptom relief than either agent alone. In asthma, beta-agonists are central and anticholinergics add limited additional benefit; steroids like Solumedrol are reserved for acute exacerbations, not maintenance therapy. So the combo inhaler is the best option for COPD management.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy